Alutard SQ
/ ALK-Abello
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
October 04, 2025
Characterizing Systemic Reactions During Subcutaneous Immunotherapy for House Dust Mite Allergies in China: Insights From a Cluster Analysis Study.
(PubMed, Allergy Asthma Immunol Res)
- "Asthma, disease duration, high sensitization, and polysensitization emerge as independent risk factors for SRs. Our cluster analysis delineates distinct clinical phenotypes of SRs, offering tailored interventions for the personalized management of patients experiencing SRs."
Journal • Allergic Rhinitis • Allergy • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases
July 25, 2025
Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
(clinicaltrials.gov)
- P1/2 | N=36 | Not yet recruiting | Sponsor: University of Zurich | Initiation date: May 2025 ➔ Aug 2025
Trial initiation date • Allergic Rhinitis • Allergy • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases
March 26, 2025
Experience with ALUTARD SQ Immunotherapy in Patients Allergic to Hymenoptera Venom
(EAACI 2025)
- "Two underwent SCT with Apis, both with tolerance including one patient monosensitized to Api m 10 Conclusion Alutard SQ was found to be safe both during transitions and with a build-up cluster protocol in 3 weeks, even among patients with mastocytosis. In patients who experienced re-stings, the efficacy of this treatment was confirmed."
Clinical • Immunology
May 07, 2025
Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
(clinicaltrials.gov)
- P1/2 | N=36 | Not yet recruiting | Sponsor: University of Zurich
New P1/2 trial • Allergic Rhinitis • Allergy • Asthma • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases
May 16, 2024
Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever
(clinicaltrials.gov)
- P3 | N=18 | Completed | Sponsor: Imperial College London | Unknown status ➔ Completed
Trial completion • Allergic Rhinitis • Immunology • Inflammation
1 to 5
Of
5
Go to page
1